TITLE

Review: anticholinergics in addition to β2 agonists improve outcome in children and adults with acute asthma

AUTHOR(S)
Rodrigo, G. J.; Castro-Rodriguez, J. A.
PUB. DATE
February 2006
SOURCE
Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p21
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on a study which reviews various research to determine whether inhaled anticholinergic agents plus β2 agonists can enhanced outcome in children and adults with acute asthma exacerbations compared to β2 agonists alone. The studies examined used randomized controlled trials. Findings indicated that the inhaled anticholinergic agents combined with β2 agonists was a better treatment.
ACCESSION #
20000929

 

Related Articles

  • Commentary. Thien, Frank // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p21 

    The article comments on a study by G. J. Rodrigo and colleagues which reviews various research to determine whether inhaled anticholinergic agents plus β2 agonists can enhanced outcome in children and adults with acute asthma exacerbations compared to β2 agonists alone. The meta-analysis...

  • Utilization and responsiveness of the asthma control test (ACT) at the initiation of therapy for patients with asthma: a randomized controlled trial.  // BMC Pulmonary Medicine;2012, Vol. 12 Issue 1, p14 

    The article presents information on a study which evaluates the effectiveness of the asthma control test (ACT) to find out the changes at the initiation of therapy and its utilization in the initiation of asthma treatment. The randomized controlled trial included patients who had not received...

  • High frequency chest wall oscillation for asthma and chronic obstructive pulmonary disease exacerbations: a randomized sham-controlled clinical trial. Mahajan, Amit K.; Diette, Gregory B.; Hatipoğlu, Umur; Bilderback, Andrew; Ridge, Alana; Harris, Vanessa Walker; Dalapathi, Vijay; Badlani, Sameer; Lewis, Stephanie; Charbeneau, Jeff T.; Naureckas, Edward T.; Krishnan, Jerry A. // Respiratory Research;Sep2011, Vol. 12 Issue 9, p1 

    Background: High frequency chest wall oscillation (HFCWO) is used for airway mucus clearance. The objective of this study was to evaluate the use of HFCWO early in the treatment of adults hospitalized for acute asthma or chronic obstructive pulmonary disease (COPD).Methods:...

  • Qualitative assessment of attributes and ease of use of the ELLIPTATM dry powder inhaler for delivery of maintenance therapy for asthma and COPD. Svedsater, Henrik; Dale, Peter; Garrill, Karl; Walker, Richard; Woepse, Mark W. // BMC Pulmonary Medicine;2013, Vol. 13 Issue 1, p1 

    Background Medications for respiratory disorders including asthma and chronic obstructive pulmonary disease (COPD) are typically delivered to the lung by means of a handheld inhaler. Patient preference for and ability to use the inhaler may influence their adherence to maintenance therapy, and...

  • SECTION 19: RESPIRATORY TRACT.  // MPR - Pharmacist's Edition;Summer2010, Vol. 4 Issue 2, p258 

    The article provides information on drugs for asthma and chronic obstructive pulmonary disease. It cites corticosteroids and anticholinergic drugs, including Accolate from AstraZeneca PLC, Accuneb from DEY LP, and Advair Diskus 100/50 from GlaxoSmithKline. It also mentions the indications,...

  • Moving forward.  // Pulse;2/25/2009 Early Treatment of COPD, Vol. 69, p6 

    The article offers information on the clinical trial results of the anticholinergic tiotropium (SPIRIVA®). It states that Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT®) trial recruited patients with chronic obstructive pulmonary disease to investigate the...

  • Using exhaled NO concentrations to adjust inhaled corticosteroid dose maintained asthma control and reduced the dose. Smith, A. D.; Cowan, J. O.; Brassett, K. P.; Taylor, R. // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p20 

    The article reports on a study to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic asthma. Patients aged 12-75...

  • Commentary. Rees, P. John // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p20 

    The article comments on a study by A. D. Smith and colleagues to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic...

  • Overlap Syndrome in Respiratory Medicine: Asthma and Chronic Obstructive Pulmonary Disease. Corlateanu, Alexandru; Pripa, Valeria; Montanari, Gloria; Botnaru, Victor // Journal of Cardio-Thoracic Medicine;2014, Vol. 2 Issue 1, p109 

    Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent chronic diseases in the general population. Both are characterized by similar mechanisms: airway inflammation, airway obstruction, and airway hyperresponsiveness. However, the distinction between the two obstructive...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics